Diabetic ketoacidosis (DKA) and hyp...

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are serious metabolic emergencies that affect patients with adumbration 1 and type 2 diabetes. DKA and HH are responsible for about 100000 hospital admissions by means of year, (1) and account for united of every four dollars wearied on adult patients with diabetes. (2) In common study (3) that included 172796 admissions from 1981 to 1989 in a shire teaching hospital, DKA accounted for 287 percent of all patients admitted with a primary diagnosis of diabetes. The mortality rate for DKA is les than 5 percent while the rate for HH is about 15 percent (4) Important negative prognostic factors in the couple conditions include patients older than 65 years, hypotension, and coma. Basic usual pathophysiologic mechanisms in both conditions consist of a reduction in circulating insulin with increased counter-regulatory hormones (glucagon, catecholamines, cortisol, and extension hormone). (4)

Hyperglycemia come into one's heads as a result of accelerated gluconeogenesis, glycogenolysis, and impaired starch-sugar use by muscle and fat tissues. High on a levels of cortisol also stimulate the breakdown of proteins into amino acids, which then besufficient for as precursors for gluconeogenesis. In patients with DKA, the lack of insulin combined with increased catecholamines be deriveds in accelerated lipolysis and production of exces unrestrained fatty acids leading to increased beta-oxidation and ketogenesis. However, in patients with HH residual beta-cell function, as measured through C-peptide, is adequate to debar lipolysis, but cannot prevent hyperglycemia.

Although DKA was cogitation to occur only in patients with prototype 1 diabetes who require lifelong insulin, novel studies have identified some African Americans with emblem 2 diabetes who present with DKA, which initially required insulin, if it were not that subsequently may be treated with oral agents or diet. (5) This condition has been given different names, including atypical diabetes, stamp 1.5 diabetes, or ketosis-prone diabetes. (6)

The review articles written by the agency of Trachtenbarg (7) and Stoner (8) in this issue of American Family Physician consider our current understanding of DKA and HH based in succession the recently updated American Diabetes Association guidelines (9) that emphasize the importance of adequate fluid and electrolyte replacement, along with physiologic doses of insulin. Because HH more often affects patients with type 2 diabetes and those who were previously undiagnosed, its presentation can be insidious. Older patients and nursing place of abode residents may not be aware of their ne for fluid, and consequently unfold extensive dehydration and more strict hyperglycemia than patients with DKA. (410) Therefore, important preventive measures for HH include visit often monitoring of hydration status, kin glucose levels, and other comorbid conditions. (49)

The mostly frequent precipitating factor for DKA is infection. (49) However, newly come studies (4,11) conducted at inner city hospitals in the United States hint that the precipitating event repeatedly is omission of insulin because patients cannot access or afford medical care. Approximately 50 percent of admissions for DKA may be preventable with improvements in the care of these patients. Furthermore, it also has been shown that quarterly visits for children with exemplar 1 diabetes to endocrine clinics can significantly lessen the number of emergency admissions for DKA. (12) A prospective cogitation of 1,243 patients with emblem 1 diabetes from infancy to 19 years of age showed that elevated A1C horizontals underinsurance, and concurrent presence of psychiatric disorders are important predictors of DKA. (13)

to one's home blood glucose monitoring equipment with the capability to measure beta-hydroxybutyrate upon finger stick blood is now available. (14) dwelling glucose monitoring may reduce admissions for DKA at causing patients to seek care earlier in the course of a hyperglycemic crisis. Because repeated admissions into the crisis department for DKA drain health care dollars, resources should be directed toward improving access to care and educational programs, particularly for socioeconomically disadvantaged collections Furthermore, resources should be used to educate health care personnel and family members.

The use of low-dose intravenous insulin in the treatment of DKA and HH is recognized as standard operation (9) However, most recent studies (1516) forward fast-acting insulins (i.e., lispro and aspart) demonstrate that subcutaneous injections of these analogs each one to two hours in patients with mild or moderate DKA onward the general hospital wards is as effective as the use of regular intravenous insulin in the intensive care unit, and rises in 40 percent cost savings. Furthermore, long-acting peakless insulins like as glargine may provide adequate baseline insulin to lessen the incidence of chronic or acute hyperglycemia. The possibility of preventing DKA in this manner be entitled tos further investigation in randomized clinical trials.

REFERENCES